FindTrial
Sign In

A Study for SARS-COV-2 RNA Level in Blood and Excrement of Novel Coronavirus Pneumonia (COVID-19) Convalescent Patients

Detection of SARS-COV-2 RNA Level in Blood and Excrement of Patients Infected with 2019-nCOV in Recovery Period

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031014
Enrollment
Unknown
Registered
2020-03-21
Start date
2020-03-19
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

2019-nCOV Disease

Interventions

SARS-COV-2 RNA Positive group:None
SARS-COV-2 RNA Negative group:None

Sponsors

HwaMei Hospital, University of Chinese Academy of Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged >14years old; 2. The diagnosis conforms to the "Diagnosis and Treatment Plan for Pneumonia Infected in novel coronavirus"

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Serum SARS-COV-2 RNA;Swallow swab SARS-COV-2 RNA;feces SARS-COV-2 RNA;Sputum SARS-COV-2 RNA;Urine SARS-COV-2 RNA;—

Countries

China

Contacts

Public ContactRengbin Ji

HwaMei Hospital, University of Chinese Academy of Sciences

rengbinji@163.com+86 13989370664

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026